Effective January 3, 2017, the Board of Directors (the Board) of
NewLink Genetics Corporation (the Company) (i) approved 2016
bonuses and supplemental bonuses for the Companys named executive
officers (as defined in Item 402(a)(3) of Regulation S-K
promulgated by the Securities and Exchange Commission and with
respect to the Companys 2016 fiscal year) and (ii) approved 2017
compensation for the named executive officers for the 2017 fiscal
year, including salaries, target bonus percentages and stock
option awards.

2016 Bonuses and Supplemental Bonuses

The 2016 bonus awards for the applicable named executive officers
are set forth on Exhibit 10.1 attached hereto and incorporated
herein by reference. The 2016 bonus awards for the applicable
named executive officers are based on the achievement of
corporate and individual goals previously approved by the Board.
Each of the awards represents 50% of the officers respective
bonus targets.

The 2016 supplemental bonus awards for the applicable named
executive officers are set forth on Exhibit 10.1 attached hereto
and incorporated herein by reference. The 2016 supplemental bonus
awards for the applicable named executive officers were paid to
compensate such named executive officers for their efforts in
successfully completing the Companys restructuring that was
effected in August 2016.

2017 Named Executive Officer Compensation

The 2017 base salaries, target bonus awards and stock option
awards for the applicable named executive officers are set forth
on Exhibit 10.2 attached hereto and incorporated herein by
reference. The 2017 salaries are unchanged from 2016. The 2017
target bonus awards for the applicable named executive officers
will be based on the achievement of corporate and individual
goals, as approved by the Board. The 2017 stock option awards
were granted on January 3, 2017.

Section 9 – Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits

(d) Exhibits